DoD Peer Reviewed Orthopaedic Translational Research Award

Post Date

April 30th 2014

Application Due Date

October 24th 2014

Funding Opportunity Number

W81XWH-14-PRORP-TRA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $2250000

• Award Range:

  $None - $None

Grant Description

The PRORP Translational Research Award is designed to support multidisciplinary translational research that will accelerate the movement of promising ideas in orthopaedic research into clinical applications to benefit Warfighters and Veterans recovering from traumatic orthopaedic injuries. To encourage meaningful and productive multidisciplinary collaborations, there must be at least one laboratory scientist and at least one clinician participating in the research. A clinician is defined as an individual who is credentialed (possesses the necessary degrees, licenses, and other certifications) and practicing as a care provider in a relevant capacity. In addition, at least one member of the research team must have significant experience in either orthopaedic or musculoskeletal research or medicine. Biographical sketches should include appropriate documentation of credentials. It is the responsibility of the Principal Investigator (PI) and the collaborating investigators to describe how their combined expertise will better address the research question, why the work should be performed through collaboration rather than through separate efforts, and how the research design will create a reciprocal flow of ideas and information between the multiple disciplines represented. The proposed collaboration should involve substantial contributions from each of the key collaborators identified, with evidence of significant intellectual input from each key collaborator into the design of the project. Applications are being solicited in the following focus areas: Identify and reduce the secondary health effects (e.g., joint contracture, obesity, metabolic syndrome, poor bone health) that follow reduced mobility from traumatic neuromusculoskeletal injury; Strategies to inhibit neuromas at surgical/amputation sites; The application of novel and/or innovative technologies and materials in prosthetic and orthotic device development; Research toward osseointegration of upper extremity prostheses; Research on treatment of non-battle orthopaedic injuries that impact unit readiness and reflect historical return to work rates less than 50% or longer than 6 months.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  301-682-5507; help@eBRAP.org

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@eBRAP.org